The information on this part of the website is intended only for health care professionals.I am an expert within the meaning of Act No. country xy. I herewith confirm that I am a professional according to this definition.
Unfortunately, as you are not a health care professional we cannot provide you this information.
BioGaia® recognizes the importance of clinical trials to establish the properties but more importantly the safety of the probiotics used in its products.
As such, BioGaia® has conducted numerous clinical trials on the use of Limosilactobacillus reuteri strains as a food supplement. To date, there have been 266 clinical studies on BioGaia®’s human strains of Limosilactobacillus reuteri with approximately 22,634 individuals of all ages (> 70% percent in children). Limosilactobacillus reuteri has proven effective in regulating the bacterial balance in the gut and completely safe for both children and adults. The results of studies have been published in numerous articles in various scientific journals, a testimony to its high relevance.
Although valuable, not all bacteria referred to as probiotics are equal. Strain specificity in probiotics is important because different strains can have different properties. Clinical studies should therefore be conducted with the specific strain or strain combination used in the final product, and at the relevant concentration, so that the study results are applicable to that product.
Limosilactobacillus reuteri Protectis® (DSM 17938) is one of BioGaia®’s most researched probiotic strains, particularly in infants and children. This specific strain has been studied in 186 completed clinical trials involving approximately 19,204 individuals, 83 percent of whom were children. Its safety and use have been evaluated across different age groups, including infants, children and adults. The results have been published in peer-reviewed scientific journals, contributing to the scientific documentation behind this specific strain.
Clinical studies help explain the evidence behind BioGaia® probiotics. To understand how this research connects to probiotic quality, strain-specific knowledge and product development, continue with EvidenceBiotics® — BioGaia®’s approach to making probiotic quality easier to understand.
